Bahija Jallal's Net Worth
$2.06 Million
Who is Bahija Jallal?
Bahija Jallal has an estimated net worth of $2.06 Million. This is based on reported shares across multiple companies, which include ArriVent Biopharma, Inc., Elevance Health, Inc., and Guardant Health, Inc..
SEC CIK
Bahija Jallal's CIK is 0001730038
Past Insider Trading and Trends
2019 was Bahija Jallal's most active year for acquiring shares with 3 total transactions. Bahija Jallal's most active month to acquire stocks was the month of April. 2022 was Bahija Jallal's most active year for disposing of shares, totalling 1 transactions. Bahija Jallal's most active month to dispose stocks was the month of May. 2024 saw Bahija Jallal paying a total of $0.00 for 17,884 shares, this is the most they've acquired in one year. In 2022 Bahija Jallal cashed out on 1,814 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ArriVent Biopharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Elevance Health, Inc. (ELV) Snapshot price: $497.695
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.67% | 457 |
—
|
—
| 3.8K |
May 10
| |||
Form 4
| +15.16% | 440 |
—
|
—
| 3.34K |
May 18
| |||
Form 4
| +20.46% | 493 |
—
|
—
| 2.9K |
May 26
| |||
Form 4
| +40.88% | 699 |
—
|
—
| 2.41K |
May 21
| |||
Form 4
| +78.68% | 753 |
—
|
—
| 1.71K |
May 15
| |||
Form 4
| +369.12% | 753 |
—
|
—
| 957 |
May 16
| |||
Form 4
|
∞
| 204 |
—
|
—
| 204 |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Guardant Health, Inc. (GH) Snapshot price: $22.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +32.43% | 1.81K |
—
|
—
| 7.41K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +97.18% | 2.76K |
—
|
—
| 5.59K |
Jun 12
| |||
Form 4
|
∞
| 2.84K |
—
|
—
| 2.84K |
Apr 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Immunocore Holdings plc (IMCR) No price found
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||